NuCana PLC added Cyrille Leperlier to its board as an independent nonexecutive director.
Leperlier was most recently a senior scientific adviser for Sanofi's corporate business development and M&A group.
U.K.-based NuCana is a clinical-stage biopharmaceutical company that develops products for treating cancer.
